Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Miahelsa HoldingsTSE:7129 +0.17%42 Debt-to-Equity is 1.50 as of Mar. 2026, which is 1% above its 10-year median of 1.49. GuruFocus rates TSE:7129 with a GF Score™ of 42/100 and a GF Value™ of 円1,069.22 (Fairly Valued). The stock has 1 warning sign investors should review. Among 564 Healthcare Providers & Services companies, Miahelsa Holdings ranks worse than 65.78% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Miahelsa Holdings's Debt-to-Equity or its related term are showing as below:
TSE:7129'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.89 Med: 1.49 Max: 1.64
Current: 0.76
During the past 5 years, the highest Debt-to-Equity Ratio of Miahelsa Holdings was 1.64. The lowest was 0.89. And the median was 1.49.
TSE:7129's Debt-to-Equity is ranked worse than 65.78% of 564
companies
in the Healthcare Providers & Services industry
Industry Median: 0.425
vs TSE:7129: 0.76
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Miahelsa Holdings Debt-to-Equity Related Terms
Miahelsa Holdings Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Miahelsa Holdings's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Miahelsa Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Miahelsa Holdings Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Miahelsa Holdings's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Miahelsa Holdings's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Miahelsa Holdings (TSE:7129) has a Debt-to-Equity of 1.50 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Miahelsa Holdings and its competitors. This is near median its historical median of 1.49. Over the past decade, Miahelsa Holdings' Debt-to-Equity has ranged from 0.89 to 1.64. According to the industry distribution chart, Miahelsa Holdings ranks #371 out of 564 companies in the Healthcare Providers & Services industry, placing it in the top 65.8%.
Is Miahelsa Holdings' Debt-to-Equity too high?
Miahelsa Holdings' current Debt-to-Equity of 1.50 is near median its 10-year median of 1.49. Over the past 10 years, this metric has ranged from a low of 0.89 to a high of 1.64. The Healthcare Providers & Services industry median Debt-to-Equity is 0.43. Miahelsa Holdings' value of 1.50 is 252.9% above this industry median. Based on the distribution chart, Miahelsa Holdings ranks #371 out of 564 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Miahelsa Holdings has a GF Score™ of 42/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Miahelsa Holdings' Debt-to-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Miahelsa Holdings ranks #371 out of 564 companies for Debt-to-Equity. This places Miahelsa Holdings in the lower half of its industry. The industry median Debt-to-Equity is 0.43. Miahelsa Holdings' value of 1.50 is 252.9% above this benchmark. Historically, Miahelsa Holdings' own Debt-to-Equity has ranged from 0.89 to 1.64 over the past decade. While the company's 10-year median is 1.49 vs. the industry median of 0.43, Miahelsa Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.43, based on 564 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Miahelsa Holdings's current Debt-to-Equity of 1.50 is 252.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Miahelsa Holdings and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Miahelsa Holdings's current Debt-to-Equity is 1.50, which is near median its own 10-year median of 1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Miahelsa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Miahelsa Holdings (TSE:7129) is currently considered Fairly Valued. The stock's GF Value™ is 円1,069.22, compared to a current price of 円1,178.00 — trading 10.2% above its estimated fair value. The current Debt-to-Equity is 1.50, which is near median its 10-year median of 1.49 and 252.9% above the Healthcare Providers & Services industry median of 0.43. Miahelsa Holdings' overall GF Score™ is 42/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Miahelsa Holdings (TSE:7129), the current Debt-to-Equity is 1.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Miahelsa Holdings (TSE:7129) Overvalued in 2026?
Based on GuruFocus' analysis, Miahelsa Holdings stock appears to be overvalued.
The current stock price of 円1,178.00 is trading 10.2% above its estimated GF Value™ of 円1,069.22.
GuruFocus considers Miahelsa Holdings to be Fairly Valued.
Key valuation signals for TSE:7129:
Debt-to-Equity: 1.50 (near median its 10-year median of 1.49)
GF Value™: 円1,069.22 vs. price of 円1,178.00 (10.2% above fair value)
Industry Position: 252.9% above the Healthcare Providers & Services median (#371 of 564)
No single metric tells the full story. See the TSE:7129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Miahelsa Holdings Corp, along with its subsidiaries, operates in the following reportable segments: Pharmaceutical Business, Nursing Care Business, and Childcare Business. The majority of its revenue is generated from the Pharmaceuticals Business, which operates pharmaceutical dispensaries in Japan through Nissei Pharmacy and Miahelsa Pharmacy brands, and also offers home care services. The Nursing care business mainly provides housing, medical care, nursing care, prevention, and lifestyle support for elderly people, and the Childcare segment involves the operation of licensed childcare centers. In addition, the group also operates a food business providing food suitable for all ages, from infants to the elderly.
42GF Score
Get the complete analysis for TSE:7129
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7129 has been successfully added to your 
